Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial

作者：Shun Lu, Shun Lu, Nong Yang, Jie Wang, Nong Yang, Dongqing Lv, Lijuan Chen, Longhua Sun, Xingya Li, Longhua Sun, Yongfeng Yu, Bo Jin, Lin Yang, Yubiao Guo, Xu H, Tienan Yi, Aiping Zeng, Xiaorong Dong, Jianhua Chen, Ziping Wang, Hongrui Niu, Ying Cheng, Hongming Pan, Pengbo Deng, Hongming Pan, Xuhong Min, Jun Bai, Juan Li, Tongmei Zhang, Juan Li, Songhua Fan, Michael M. Shi, Tony Mok, Weiguo Su, Shun Lu, Shun Lu, Jie Wang, Jie Wang, Nong Yang, Dongqing Lv, Lijuan Chen, Lin Wu, Xingya Li, Longhua Sun, Haipeng Xu, Bo Jin, Lin Yang, Yubiao Guo, Xu H, Tienan Yi, Aiping Zeng, Xiaorong Dong, Jianhua Chen, Ziping Wang, Hongrui Niu, Ying Cheng, Pinhua Pan, Pengbo Deng, Hongming Pan, Xuhong Min, Jun Bai, Laiyu Liu, Tongmei Zhang, Juan Li, Songhua Fan, Michael M. Shi, Tony Mok, Weiguo Su, Feng Ye, Xianling Liu, Jianhua Shi, Jiwei Liu, Qisen Guo, Weihua Yang, Junfang Tang, Shundong Cang, Ou Jiang, Jian Fang, Guohua Yu, Lijun Wang, Xibin Zhuang, Zhigang Han, Yiping Zhang, Zhengbo Song, Baogang Liu, Buhai Wang, Jianying Zhou, Wei Gu, Hongcheng Wu, Zhiwei Lu, Yan Yang, Wen Dong, Xiuhua Fu, Youling Gong, Jinhuo Lai, Ping Sun, Yingying Du, Zhihua Liu, Diansheng Zhong, Kaihua Lu, Jianghong Wang, Jianghong Wang, Zhaohong Chen, Xiujie Cui, Zhengxiang Han, Yu Yao, Fang Zhang, Yunchao Huang, Haichuan Su, Zhennan Yi, Lin Li, Tongjian Cui, Puhan Lu, Xiangdong Wang, Jie Yu, Huan Yan, Xian Luo, Yongxin Ren · 发表于：The Lancet · 年份：2026 · DOI：10.1016/s0140-6736(25)01811-2 · 被引用次数：20 · 研究领域：Lung Cancer Treatments and Mutations、Fibroblast Growth Factor Research、Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis